• About us
• Contact

Advertisement

Person › Details

Martine Clozel (Actelion Ltd. (SIX: ATLN))

Clozel, Martine (Actelion 201108 CSO)

 

	Organisation	Actelion Ltd. (SIX: ATLN)
	Group	Johnson & Johnson (JnJ) (Group)
	Product	Tracleer®
	Product 2	ponesimod

Record changed: 2024-07-17

Advertisement

More documents for Martine Clozel

• [1] Idorsia Ltd.. (4/11/24). "Press Release: Idorsia Takes Steps to Address Short-term Liquidity Needs". Allschwil....
• [2] Idorsia Ltd.. (3/20/24). "Press Release: US FDA Approves Idorsia’s Once-daily Tryvio (aprocitentan) – the First and Only Endothelin Receptor Antagonist for the Treatment of High Blood Pressure Not Adequately Controlled in Combination with other Antihy...
• [3] Idorsia Ltd.. (5/20/20). "Press Release: Idorsia Successfully Completes the Offering of New Shares thereby Securing Funding for the Company’s Growth Plan". Allschwil....
• [4] Idorsia Ltd.. (5/19/20). "Press Release: Idorsia Launches an Offering of New Shares to Fund the Company’s Growth plan". Allschwil....
• [5] Idorsia Ltd.. (5/12/20). "Press Release: Neurocrine Biosciences Exercises Option to License Idorsia's Novel Treatment for Rare Pediatric Epilepsy". San Diego, CA & Allschwil....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.